# Functional Food Ge‐Zhi Soup Ameliorates Acute Liver Injury Through the AKT/GSK3β/PPARα Pathway

**Authors:** Xinhua Yao, Xiaowei Lu, Duanrui Cao, Lina Huang, Zhixin Zhou, Zidong Qiu, Rui Su, Ni Zhang

PMC · DOI: 10.1002/fsn3.70603 · Food Science & Nutrition · 2025-07-21

## TL;DR

Ge-Zhi soup helps reduce acute liver injury by regulating a key biological pathway and improving liver health in mice.

## Contribution

The study identifies the AKT/GSK3β/PPARα pathway as a novel mechanism through which Ge-Zhi soup protects the liver.

## Key findings

- Ge-Zhi soup reduced liver damage and improved biochemical markers in mice with acute liver injury.
- Key compounds like kaempferol and quercetin were identified as active ingredients in Ge-Zhi soup.
- The AKT/GSK3β/PPARα pathway was found to mediate Ge-Zhi soup's protective effects on liver function.

## Abstract

Ge‐Zhi soup (GZS), mainly consisting of Puerariae lobata (Willd.) Ohwi and Hovenia acerba Lindl. seeds, is a traditional functional food widely consumed globally and has been proven to have considerable potential in preventing acute liver injury (ALI). However, its specific active ingredients and underlying mechanisms remain underexplored. In this study, the hepatoprotective effects, active ingredients, and underlying mechanisms of GZS were studied in ALI mice. We first determined the hepatoprotective effects of GZS and evaluated its function by analyzing biochemical parameters and histopathological changes in ALI mice. To elucidate the underlying mechanisms, an integrated strategy combining serum pharmacochemistry, network pharmacology, and non‐targeted metabolomics was employed to identify key active compounds and core targets based on the analysis of serum and tissue from the ALI mice. The results showed GZS effectively reduced the severity of liver lesions in ALI mice, revealed by histological analysis, significantly decreased the levels of AST, ALT, and MDA, and increased the levels of GSH and SOD. A total of 81 serum components were identified, including major bioactive compounds such as kaempferol, luteolin, and quercetin, as well as critical target genes such as STAT3, SRC, and PPARA. Notably, acetylcysteine was identified as a pivotal metabolite. Mechanistically, GZS's protective effects against ALI appear to be mediated through a complex regulatory network that modulates mitochondrial function and fatty acid oxidative metabolism, primarily via the AKT/GSK3β/PPARα pathway. This study elucidates the pharmacological basis and mechanisms of GZS in ALI, providing a theoretical basis for GZS as a novel functional food and therapeutic agent for ALI.

A network among Ge‐Zhi soup–serum compounds–genes–metabolites–ALI is established. Ge‐Zhi soup regulates lipid metabolism through improving mitochondrial dysfunction. AKT/GSK3β/PPARα pathway is regulated to reduce acute liver injury.

## Linked entities

- **Genes:** STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 6774], SRC (SRC proto-oncogene, non-receptor tyrosine kinase) [NCBI Gene 6714], PPARA (peroxisome proliferator activated receptor alpha) [NCBI Gene 5465]
- **Chemicals:** kaempferol (PubChem CID 5280863), luteolin (PubChem CID 5280445), quercetin (PubChem CID 5280343), acetylcysteine (PubChem CID 12035)

## Full-text entities

- **Genes:** Stat3 (signal transducer and activator of transcription 3) [NCBI Gene 20848] {aka 1110034C02Rik, Aprf}, Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}, Ppara (peroxisome proliferator activated receptor alpha) [NCBI Gene 19013] {aka 4933429D07Rik, Nr1c1, PPAR-alpha, PPARalpha, Ppar}, Tmprss11d (transmembrane protease, serine 11d) [NCBI Gene 231382] {aka AST, AsP}, Gpt (glutamic pyruvic transaminase, soluble) [NCBI Gene 76282] {aka 1300007J06Rik, 2310022B03Rik, ALT, ALT1, Gpt-1, Gpt1}, Gsk3b (glycogen synthase kinase 3 beta) [NCBI Gene 56637] {aka 7330414F15Rik, 8430431H08Rik, GSK-3, GSK-3beta, GSK3}, Src (src proto-oncogene, non-receptor tyrosine kinase) [NCBI Gene 20779] {aka pp60c-src}
- **Diseases:** ALI (MESH:D017114), liver lesions (MESH:D008107)
- **Chemicals:** luteolin (MESH:D047311), acetylcysteine (MESH:D000111), quercetin (MESH:D011794), fatty acid (MESH:D005227), kaempferol (MESH:C006552), MDA (MESH:D015104)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12280231/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12280231/full.md

## References

53 references — full list in the complete paper: https://tomesphere.com/paper/PMC12280231/full.md

---
Source: https://tomesphere.com/paper/PMC12280231